Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.060
-0.040 (-1.90%)
At close: Jun 23, 2026, 4:00 PM EDT
2.070
+0.010 (0.48%)
After-hours: Jun 23, 2026, 5:23 PM EDT
Compass Therapeutics Employees
Compass Therapeutics had 39 employees as of December 31, 2025. The number of employees increased by 4 or 11.43% compared to the previous year.
Employees
39
Change (1Y)
4
Growth (1Y)
11.43%
Revenue / Employee
n/a
Profits / Employee
-$1,748,026
Market Cap
370.98M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | 4 | 11.43% |
| Dec 31, 2024 | 35 | 3 | 9.38% |
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Verastem | 102 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
| Atea Pharmaceuticals | 55 |
CMPX News
- 14 days ago - Compass Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 19 days ago - Compass Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 26 days ago - Compass Therapeutics to Participate in Upcoming June Investor Events - GlobeNewsWire
- 4 weeks ago - Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 4 weeks ago - Compass Therapeutics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 5 weeks ago - Compass Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 6 weeks ago - Compass Therapeutics to Participate in Upcoming May Investor Events - GlobeNewsWire
- 7 weeks ago - Compass Therapeutics reports Q1 EPS (10c), consensus (10c) - TheFly